- Docente: Daniele Fabbri
- Credits: 5
- SSD: SECS-P/03
- Language: English
- Teaching Mode: Traditional lectures
- Campus: Bologna
-
Corso:
Second cycle degree programme (LM) in
Health Economics and Management (cod. 5902)
Also valid for Second cycle degree programme (LM) in Economics and Economic Policy (cod. 8420)
-
from Nov 06, 2023 to Dec 11, 2023
Learning outcomes
The course aims at providing student with an advanced knowledge on the economics & regulation of the biopharmaceuticals market. Biopharmaceutical markets are regulated in most countries. The objective of regulation is to assure consumers that the inputs into the health production function are of sufficiently high quality, and are made available at reasonable social costs. Regulation typically consists of some combination of different tools like regulation of market access and product safety, patent protection, pricing regulation and regulation of promotion. At the end of the course the student is aware of:
- Technological characteristics of the pharmaceutical sector and the objectives of regulation.
- Pharmaceuticals' R&D and productivity
- The economics of pharmaceutical patenting: patent extension policy, generic entry, extension of patent to developing countries.
- Pricing and reimbursement regulation
- Issues on low and middle income countries
Course contents
- Key facts and rationale for regulation in the pharmaceutical sector
- R&D and incentive to innovation
- The rationale for pharmaceutical patenting
- Demand elasticity, formulary and the buyer power
- Generics competition
- Uniform pricing vs price discrimination
- Models of pricing&reimbursement
- Issues for developing countries
Readings/Bibliography
Key readings
- Bhattacharya J, Hyde T and Tu P, 2014, Chapter 12 “Pharmaceuticals and the economics of innovation” in Health Economics, Palgrave McMillan.
- Lakdawalla D, 2018, “Economics of the Pharmaceutical Industry”, Journal of Economic Literature, 56(2), 397 – 449.
- Sloan FA and Hsieh C-R, 2012, Health Economics, MIT Press, Cambridge, Massachussets, chapter 9
- Scott Morton and Kyle, 2012, "Markets for Pharmaceutical Products", in Pauly, Mcguire and Barros (eds), Handbook of Health Economics, Volume 2, Elsevier.
Other
- Danzon P and Nicholson S, 2012, The Oxford Handbook of the Economics of Biopharmaceutical Industry, Oxford University Press (DN)
Additional reading will be given during the course from the following: Journal of Health Economics, Journal of Economic Perspectives, New England Journal of Medicine, Health Affairs, ....
Teaching methods
Lectures, seminars and class discussions.
Assessment methods
The overall assessment will consist of a WRITTEN EXAM. The written exam is a closed book exam. You will have 90 minutes to complete it. Further details (and a sample exam) will be given in class.
GRADING
Grades are expressed on a 18-30 scale and graduated as follows:
<18 failed
18-23 sufficient
24-27 good
28-30 very good
30 L excellent
Further details on the assessment metods and grading will be provided at the beginning of the classes.
Teaching tools
We will use Unibo e-learning platform (VIRTUALE.UNIBO.IT) for remote downloading of teaching materials and uploading of assigned teamworks.
Details on how to access the remote learning platform will be provided at the beginning of the course.
Office hours
See the website of Daniele Fabbri